(Q44390014)

2 December 2017

Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources (English)

1 reference

2 December 2017

Souillet G

1

1 reference

2 December 2017

Guffon N

2

1 reference

2 December 2017

Maire I

3

1 reference

2 December 2017

Pujol M

4

1 reference

2 December 2017

Taylor P

5

1 reference

2 December 2017

Sevin F

6

1 reference

2 December 2017

Bleyzac N

7

1 reference

2 December 2017

Mulier C

8

1 reference

2 December 2017

Durin A

9

1 reference

2 December 2017

Kebaili K

10

1 reference

2 December 2017

Galambrun C

11

1 reference

2 December 2017

Bertrand Y

12

1 reference

2 December 2017

Froissart R

13

1 reference

2 December 2017

Dorche C

14

1 reference

2 December 2017

Gebuhrer L

15

1 reference

2 December 2017

Garin C

16

1 reference

2 December 2017

Berard J

17

1 reference

2 December 2017

Guibaud P

18

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Bone Marrow Transplantation

2 December 2017

1 reference

2 December 2017

31

1 reference

2 December 2017

12

1 reference

2 December 2017

1105-1117

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704105

2 December 2017

0 references

cites work

Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

Long-term outcome of Hurler syndrome following bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

Follow-up of nine patients with Hurler syndrome after bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

Diagnosis of mucopolysaccharidoses in a clinically selected population by urinary glycosaminoglycan analysis: a study of 2,000 urine samples

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

Alpha-L-iduronidase activity in cultured skin fibroblasts and amniotic fluid cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

Prenatal diagnosis of Hurler disease by analysis of alpha-iduronidase in chorionic villi

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

A division of HLA-DQw1 associated with DR1, DR1x-DQw1, DR2 short, DRw10, and DRw14. I. Definition by alloantiserum LY 1327.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

DNA typing of DRw6 subtypes: correlation with DRB1 and DRB3 allelic sequences by hybridization with oligonucleotide probes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

Characterization of a panel of highly variable minisatellites cloned from human DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

Mucopolysaccharidosis type I: identification of 8 novel mutations and determination of the frequency of the two common alpha-L-iduronidase mutations (W402X and Q70X) among European patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

alpha-L-iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotype.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

Enzyme-replacement therapy in mucopolysaccharidosis I.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704105

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704105

1 reference

Dimensions Publication ID

2 December 2017

1047158803

0 references

Fatcat ID

release_qsapom64braq3johbqwp4652ae

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qsapom64braq3johbqwp4652ae

24 November 2022

mapped directly with Wikidata item

1 reference